Piero Luigi Almasio
Piero Luigi Almasio
Dipartimento Biomedico di Medicina Interna e Specialistica - Universita' di Palermo
No verified email
Cited by
Cited by
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients
G Fattovich, G Giustina, F Degos, F Tremolada, G Diodati, P Almasio, ...
Gastroenterology 112 (2), 463-472, 1997
Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study
S Bruno, T Stroffolini, M Colombo, S Bollani, L Benvegnu, G Mazzella, ...
Hepatology 45 (3), 579-587, 2007
Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B
G Fattovich, G Giustina, SW Schalm, S Hadziyannis, J Sanchez‐Tapias, ...
Hepatology 21 (1), 77-82, 1995
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ...
Nature genetics 42 (8), 658-660, 2010
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study
G Realdi, G Fattovich, S Hadziyannis, SW Schalm, P Almasio, ...
Journal of hepatology 21 (4), 656-666, 1994
The long‐term course of chronic hepatitis B
V Di Marco, OL Iacono, C Cammà, A Vaccaro, M Giunta, G Martorana, ...
Hepatology 30 (1), 257-264, 1999
Clinical outcome of HBeAg‐negative chronic hepatitis B in relation to virological response to lamivudine
DV Di Marco, A Marzano, P Lampertico, P Andreone, T Santantonio, ...
Hepatology 40 (4), 883-891, 2004
Hepatitis C viremia in chronic liver disease: relationship to interferon‐α or corticosteroid treatment
S Magrin, A Craxi, C Fabiano, RG Simonetti, G Fiorentino, L Marino, ...
Hepatology 19 (2), 273-279, 1994
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C
G Fattovich, G Giustina, F Degos, G Diodati, F Tremolada, F Nevens, ...
Journal of hepatology 27 (1), 201-205, 1997
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis
G Fattovich, G Giustina, J Sanchez-Tapias, C Quero, A Mas, PG Olivotto, ...
The American journal of gastroenterology 93 (6), 896-900, 1998
Sustained virologic response prevents the development of esophageal varices in compensated, Child‐Pugh class A hepatitis C virus–induced cirrhosis. A 12‐year prospective follow …
S Bruno, A Crosignani, C Facciotto, S Rossi, L Roffi, A Redaelli, ...
Hepatology 51 (6), 2069-2076, 2010
Interferon‐α for chronic hepatitis C: An analysis of pretreatment clinical predictors of response
L Pagliaro, A Craxí, C Cammaá, F Tiné, V Di Marco, OL Iacono, P Almasio
Hepatology 19 (4), 820-828, 1994
Predicting Mortality Risk in Patients With Compensated HCV-lnduced Cirrhosis: A Long-Term Prospective Study
S Bruno, M Zuin, A Crosignani, S Rossi, F Zadra, L Roffi, M Borzio, ...
American Journal of Gastroenterology 104 (5), 1147-1158, 2009
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ...
Nature communications 6 (1), 1-11, 2015
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
AJ van der Meer, JJ Feld, H Hofer, PL Almasio, V Calvaruso, ...
Journal of hepatology 66 (3), 485-493, 2017
Management of hepatitis C virus genotype 4: recommendations of an international expert panel
MA Khattab, P Ferenci, SJ Hadziyannis, M Colombo, MP Manns, ...
Journal of hepatology 54 (6), 1250-1262, 2011
The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases
E Sagnelli, T Stroffolini, A Mele, P Almasio, N Coppola, L Ferrigno, ...
Journal of medical virology 75 (4), 522-527, 2005
Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis
A Andriulli, E Botteri, PL Almasio, I Vantini, G Uomo, P Maisonneuve
Pancreas 39 (8), 1205-1210, 2010
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial
V Di Marco, PL Almasio, D Ferraro, V Calvaruso, G Alaimo, S Peralta, ...
Journal of hepatology 47 (4), 484-491, 2007
IL-10 and TNF-α polymorphisms and the recovery from HCV infection
D Lio, C Caruso, R Di Stefano, GC Romano, D Ferraro, L Scola, A Crivello, ...
Human immunology 64 (7), 674-680, 2003
The system can't perform the operation now. Try again later.
Articles 1–20